期刊文献+

干扰肿瘤微环境对细胞毒性T淋巴细胞瘤体内归巢和杀伤活性的影响 被引量:2

Effect of Interfering Tumor Microenvironment on Homing and Killing Activity of Cytotoxic T Lymphocytes
下载PDF
导出
摘要 目的探讨应用低剂量环磷酰胺(cyclophosphamide,CYC)干扰荷瘤小鼠体内微环境对改善过继回输的细胞毒性T淋巴细胞(cytotoxic T lymphocyte,CTL)瘤体内归巢和杀伤活性的作用。方法建立C57BL/6荷瘤小鼠模型并分为对照组、CYC注入(CYCI)组、0.9%Na Cl溶液注入(NSI)+CTL组和CYCI+CTL组,每组40只,分别给CYCI组、CYCI+CTL组每只小鼠腹腔注入CYC(20mg/kg),NSI+CTL组小鼠注入等量0.9%Na Cl溶液。检测注射前后不同时间小鼠瘤体内调节性T细胞(Treg)、白细胞介素-10(IL-10)和转化生长因子-β(TGF-β)水平变化。于注射后第4天回输CFSE-CTL,每只0.2 ml,含5×l06个细胞。流式检测对比NSI+CTL组和CYCI+CTL组瘤体内CFSE-CTL比例。结果 NSI+CTL组小鼠Treg、IL-10、TGF-β水平随着瘤体增长而逐渐增高;CYCI+CTL组比NSI+CTL组回输的CFSE-CTL在肿瘤内归巢明显增加和持久(P<0.05)。各组肿瘤体积除对照组和CYCI组外,其余各组间差异均有统计学意义(P<0.05)。结论提前应用低剂量CYC干预荷瘤小鼠体内微环境,可降低瘤体内Treg、IL-10和TGF-β水平,使过继回输的CTL在肿瘤中的归巢聚集明显增强,杀伤肿瘤效率提高。 Objective To explore the effect of interfering tumor microenvironment with low-dose cyclophosphamide (CYC) administration on homing and killing activity of adoptive transfused cytotoxic T lymphocytes in adoptive immunotherapy.Methods Melanoma-bearing mice models were established and randomly divided into four groups:control group,CYC injection group (CYCI),the solution of 0.9% w/v of NaC1 injection plus CTL infusion group (NSI+CTL) and CYC injection plus CTL infusion group (CYCI+CTL),40 cases in each group.CYC (20 mg/kg) were intraperitoneally injected in mice of CYCI group and CYCI+CTL group.The same amount of the solution of 0.9% w/v of NaC1 was injected in mice of NSI+CTL group.The levels of Treg,TGF-β and IL-10 were detected at the different time points before and after CYC or the solution of 0.9% w/v of NaC1 injection.The cultured CFSE-CTLs were transfused at the 4th day after injection,5×106 cells per mouse.Then,CFSE-CTLs ratio was analyzed by FCM.Results In NSI+CTL group,the levels of Treg,TGF-β and IL-10 were all increased continuously with tumor growth.CFSE-CTLs ratio in CYCI+CTL group was significantly higher and lasted longer than that in NSI+CTL group (P<0.05).There was significant difference among every two group,except control group and CYCI group(P<0.05).Conclusion Tumor microenvironment in tumor-bearing mice could be effectively intervened by low-dose CYC administration in advance,with decreased Tregs,IL-10,and TGF-β levels.As a result,more transferred CTLs homing leads to the strenthened killing efficacy.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2014年第12期1286-1291,共6页 Cancer Research on Prevention and Treatment
基金 河北省科技支撑计划项目(10246139D) 国家自然科学基金(81472503)
关键词 过继性免疫治疗 细胞毒性T淋巴细胞 肿瘤微环境 免疫逃逸 Adoptive cellular immunotherapy Cytotoxic T lymphocytes Tumor microenvironment Immune escape
  • 相关文献

参考文献3

二级参考文献56

  • 1Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 2004, 21: 137-148.
  • 2Dudley ME, Rosenberg SA. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat Rev Cancer, 2003,3 : 666- 675.
  • 3Childs RW, Barrett J. Nonmyeloablative allogeneic immunotherapy for solid tumors. Annu Rev Med, 2004, 55:459- 475.
  • 4Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med, 2004, 10: 909-915.
  • 5Gattinoni L, Powell DJ Jr, Rosenberg SA, et al. Adoptive immunotherapy for cancer: building on success. Nat Rev lmmunol, 2006, 6 : 383-393.
  • 6van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. J Immunol, 2007,178 : 2617-2621.
  • 7Petvises S, Pakakasama S, Wongkajornsilp A, et al. Ex vivo generation of cytokine-induced killer ceils ( CD3 + CD56 + ) from post-stem cell transplant pediatric patients against autologous- Epstein-Barr virus-transformed lymphoblastoid cell lines. Pediatr Transplant, 2007, 11 : 511-517.
  • 8Verneris MR, Kornacker M, Mailander V, et al. Resistance of ex vivo expanded CD3 + CD56 + T cells to Fas-mediated apoptosis. Cancer Immunol Immunother, 2000, 49: 335-345.
  • 9Fang W, Wang F, Ji S. SPECT imaging of myocardial infarction using 99mTc-labeled C2A domain of synaptotagmin I in a porcine ischemia-reperfusion model. Nucl Med Biol, 2007, 34:917-923.
  • 10Ridolfi R, Riccobon A, Galassi R, et al. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med, 2004 , 2:27.

共引文献18

同被引文献23

  • 1Liang Liu,Weihong Zhang,Xiuying Qi.Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma. Clinical Cancer Research . 2012
  • 2Runmei Li,Changli Wang,Liang Liu,Chunjuan Du,Shui Cao,Jinpu Yu,Shizhen Emily Wang,Xishan Hao,Xiubao Ren,Hui Li.Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study[J]. Cancer Immunology, Immunotherapy . 2012 (11)
  • 3Hui Li,Jin-Pu Yu,Shui Cao,Feng Wei,Peng Zhang,Xiu-Mei An,Zong-Tang Huang,Xiu-Bao Ren.CD4 +CD25 + Regulatory T Cells Decreased the Antitumor Activity of Cytokine-Induced Killer (CIK) Cells of Lung Cancer Patients[J]. Journal of Clinical Immunology . 2007 (3)
  • 4Jin CG,Chen XQ,Li J,et al.Moderating effects and maintenance of lung cancer cellular immune functions by CIK cell therapy. Asian Pacific Journal of Cancer Prevention . 2013
  • 5Robert D. Schreiber,Lloyd J. Old,Mark J. Smy.Cancer Immunoediting: Integrating Immunity?s Roles in Cancer Suppression and Promotion. Science . 2011
  • 6Li-Kun Wang,Ming Kuang,Yun-Peng Hua,Qiang He,Bin Chen,Ye Wang,Bao-Gang Peng.Profile of regulatory T cells and interferon γ secretion in the tumor-draining lymph node from mouse Hepa1–6 cells[J]. Journal of Surgical Research . 2013 (2)
  • 7Frances A. Shepherd,Jean-Yves Douillard,George R. Blumenschein.Immunotherapy for Non-small Cell Lung Cancer: Novel Approaches to Improve Patient Outcome[J]. Journal of Thoracic Oncology . 2011 (10)
  • 8Andersen, Mads Hald,S?rensen, Rikke B?k,Brimnes, Marie K,Svane, Inge Marie,Becker, Jürgen C,Straten, Per thor.Identification of heme oxygenase-1-specific regulatory CD8^sup +^ T cells in cancer patients[J]. Journal of Clinical Investigation . 2009 (8)
  • 9Feliciano J,Feigenberg S,Mehta M.Chemoradiation for definitive,preoperative,or postoperative therapy of locally advanced nonsmall cell lung cancer. Cancer Journal . 2013
  • 10Katarzyna Urbanska,Evripidis Lanitis,Mathilde Poussin.A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor. Cancer Research . 2012

引证文献2

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部